Inventor · disambiguated record
Eric Yi-Chun Huang
Also filed as: HUANG ERIC YI-CHUN
21 granted patents·40 pending applications·619 citations·filing 2006–2024
96Inventor score
Top patents by PatentIndex Score
61 records- 0198US10124055B2Zika virus RNA vaccinesMODERNATX INC·Filed 2017·Granted Nov 13, 2018·107 cites·26 claims
- 0297US11278611B2Zika virus RNA vaccinesMODERNATX INC·Filed 2020·Granted Mar 22, 2022·9 cites·20 claims
- 0397US11027025B2Compositions comprising synthetic polynucleotides encoding CRISPR related proteins and synthetic sgRNAs and methods of useMODERNATX INC·Filed 2014·Granted Jun 8, 2021·40 cites·3 claims
- 0497US10709779B2Nucleic acid vaccinesMODERNATX INC·Filed 2018·Granted Jul 14, 2020·36 cites·11 claims
- 0597US10449244B2Zika RNA vaccinesMODERNATX INC·Filed 2018·Granted Oct 22, 2019·85 cites·27 claims
- 0697US10022435B2Nucleic acid vaccinesMODERNATX INC·Filed 2016·Granted Jul 17, 2018·69 cites·27 claims
- 0797US9878056B2Modified polynucleotides for the production of cosmetic proteins and peptidesMODERNATX INC·Filed 2013·Granted Jan 30, 2018·33 cites·9 claims
- 0897US9872900B2Nucleic acid vaccinesMODERNATX INC·Filed 2016·Granted Jan 23, 2018·169 cites·26 claims
- 0996US10675342B2Chikungunya virus RNA vaccinesMODERNATX INC·Filed 2018·Granted Jun 9, 2020·8 cites·28 claims
- 1096US10238731B2Chikagunya virus RNA vaccinesMODERNATX INC·Filed 2017·Granted Mar 26, 2019·10 cites·28 claims
- 1195US11576961B2Broad spectrum influenza virus vaccineMODERNATX INC·Filed 2018·Granted Feb 14, 2023·30 cites·24 claims
- 1294US11364292B2CHIKV RNA vaccinesMODERNATX INC·Filed 2020·Granted Jun 21, 2022·3 cites·20 claims
- 1393US11235052B2Chikungunya virus RNA vaccinesMODERNATX INC·Filed 2020·Granted Feb 1, 2022·3 cites·20 claims
- 1492US12329812B2Nucleic acid vaccinesMODERNATX INC·Filed 2024·Granted Jun 17, 2025·0 cites·1 claims
- 1592US12274743B2Nucleic acid vaccinesMODERNATX INC·Filed 2024·Granted Apr 15, 2025·0 cites·1 claims
- 1689US10517940B2Zika virus RNA vaccinesMODERNATX INC·Filed 2018·Granted Dec 31, 2019·4 cites·25 claims
- 1787US11007260B2Infectious disease vaccinesMODERNATX INC·Filed 2016·Granted May 18, 2021·4 cites·19 claims
- 1886US10881730B2Immunomodulatory therapeutic MRNA compositions encoding activating oncogene mutation peptidesMODERNATX INC·Filed 2019·Granted Jan 5, 2021·8 cites·44 claims
- 1984US2024366745A1Tropical disease vaccinesMODERNATX INC·Filed 2024·Application pending·0 cites
- 2084US2025135010A1Concatemeric peptide epitope rnasMODERNATX INC·Filed 2024·Application pending·0 cites
- 2181US2024398927A9Nucleic acid vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 2280US2022257746A1Tropical disease vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 2379US12150980B2Concatemeric peptide epitope RNAsMODERNATX INC·Filed 2016·Granted Nov 26, 2024·1 cites·20 claims
- 2479US2023020362A1Infectious disease vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 2577US2021220467A1Nucleic acid vaccinesMODERNATX INC·Filed 2021·Application pending·0 cites
- 2673US2019008948A1Nucleic acid vaccinesMODERNATX INC·Filed 2018·Application pending·0 cites
- 2772US2019015501A1Nucleic acid vaccinesMODERNATX INC·Filed 2018·Application pending·0 cites
- 2871US2022152178A1Concatemeric peptide epitope rnasMODERNATX INC·Filed 2021·Application pending·0 cites
- 2970US2025170235A1Messenger ribonucleic acids for enhancing immune responses and methods of use thereofMODERNATX INC·Filed 2024·Application pending·0 cites
- 3070US2020368343A1Zika virus mrna vaccinesMODERNATX INC·Filed 2020·Application pending·0 cites
- 3168US10702597B2CHIKV RNA vaccinesMODERNATX INC·Filed 2018·Granted Jul 7, 2020·0 cites·24 claims
- 3268US2023310576A1Broad spectrum influenza virus vaccineMODERNATX INC·Filed 2022·Application pending·0 cites
- 3367US2022111079A1COMPOSITIONS COMPRISING SYNTHETIC POLYNUCLEOTIDES ENCODING CRISPR RELATED PROTEINS AND SYNTHETIC SGRNAs AND METHODS OF USEMODERNATX INC·Filed 2021·Application pending·0 cites
- 3465US2016243221A1Compositions and methods for tolerizing cellular systemsMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3561US2016136236A1Compositions and Methods of Altering Cholesterol LevelsMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3660US11603399B2Long-lived polynucleotide moleculesMODERNATX INC·Filed 2017·Granted Mar 14, 2023·0 cites·15 claims
- 3760US2019192653A1Compositions and methods for tolerizing cellular systemsMODERNATX INC·Filed 2018·Application pending·0 cites
- 3859US2025041393A1Polynucleotides encoding integrin beta-6 and methods of use thereofMODERNATX INC·Filed 2022·Application pending·0 cites
- 3959US2020261572A1Messenger ribonucleic acids for enhancing immune responses and methods of use thereofMODERNATX INC·Filed 2019·Application pending·0 cites
- 4057US2016024181A1Long-lived polynucleotide moleculesMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4156US2019351039A1Immunomodulatory therapeutic mrna compositions encoding activating oncogene mutation peptidesMODERNATX INC·Filed 2018·Application pending·0 cites
- 4256US2021128721A1Immunomodulatory therapeutic mrna compositions encoding activating oncogene mutation peptidesMODERNATX INC·Filed 2020·Application pending·0 cites
- 4355US2018291335A1Modified polynucleotides for altering cell phenotypeMODERNATX INC·Filed 2017·Application pending·0 cites
- 4453US2022280639A1Compositions and methods for delivery of rna interference agents to immune cellsMODERNATX INC·Filed 2020·Application pending·0 cites
- 4553US2017173128A1Targeted adaptive vaccinesMODERNA TX INC·Filed 2014·Application pending·0 cites
- 4652US2015315541A1Modified polynucleotides for altering cell phenotypeMODERNA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4751US2024401006A1Mrnas encoding chimeric metabolic reprogramming polypeptides and uses thereofMODERNA TX INC·Filed 2022·Application pending·0 cites
- 4849US2018311343A1Messenger ribonucleic acids for enhancing immune responses and methods of use thereofMODERNATX INC·Filed 2018·Application pending·0 cites
- 4946US2023112857A1Methods of making tolerogenic dendritic cellsMODERNATX INC·Filed 2021·Application pending·0 cites
- 5046US2024123034A1Mrnas encoding granulocyte-macrophage colony stimulating factor for treating parkinson's diseaseMODERNATX INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Eric Yi-Chun Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →